Synektik (WAR:SNT) Beta: 1.4671 (As of Jul. 09, 2026)


WAR:SNT Synektik SA WAR:SNT
85 GF Score
Price zł381.80
GF Value zł227.58
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Synektik Beta?

Synektik WAR:SNT +1.43% 85 Beta is 1.4671 as of Jul. 09, 2026. GuruFocus rates WAR:SNT with a GF Score™ of 85/100 and a GF Value™ of zł227.58 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-09), Synektik's Beta is 1.4671.


Synektik  (WAR:SNT) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Synektik Beta Related Terms


Synektik Beta Historical Data

* Premium members only.

The historical data trend for Synektik's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Synektik Beta Chart

Synektik Annual Data
Trend Dec14 Dec15 Dec16 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.21 1.02 0.85 0.85 1.29

Synektik Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.35 1.21 1.48 1.48 1.39

WAR:SNT vs ABT, SYK, MDT: Beta Comparison

For the Medical Devices subindustry, Synektik's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Synektik Beta vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Synektik's Beta distribution charts can be found below:

* The bar in red indicates where Synektik's Beta falls into.


WAR:SNT
85GF Score
Synektik SA WAR:SNT
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Synektik Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 1.4671 mean?
Synektik (WAR:SNT) has a Beta of 1.4671 as of Jul. 09, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Synektik and its competitors.
Is Synektik's Beta too high?
Synektik's current Beta is 1.4671. Overall, Synektik has a GF Score™ of 85/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Synektik's Beta compare to ABT and SYK?
Synektik's Beta of 1.4671 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Medical Devices & Instruments company?
A good Beta depends on the Medical Devices & Instruments industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Synektik and its competitors. Synektik's current Beta is 1.4671. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synektik stock overvalued right now?
Based on GuruFocus' analysis, Synektik (WAR:SNT) is currently considered Significantly Overvalued. The stock's GF Value™ is zł227.58, compared to a current price of zł381.80 — trading 67.8% above its estimated fair value. The current Beta is 1.4671. Synektik's overall GF Score™ is 85/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Synektik (WAR:SNT), the current Beta is 1.4671 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Synektik (WAR:SNT) Overvalued in 2026?

Based on GuruFocus' analysis, Synektik stock appears to be overvalued. The current stock price of zł381.80 is trading 67.8% above its estimated GF Value™ of zł227.58. GuruFocus considers Synektik to be Significantly Overvalued.

Key valuation signals for WAR:SNT:

  • Beta: 1.4671
  • GF Value™: zł227.58 vs. price of zł381.80 (67.8% above fair value)
  • GF Score™: 85/100 with 7 warning signs

No single metric tells the full story. See the WAR:SNT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Synektik Business Description

Other Exchanges A2P:Germany
Address Aleja Wincentego Witosa 31, Warsaw, POL, 00-710
Synektik SA is a supplier of innovative products, services and IT solutions for diagnostic imaging and nuclear medicine. It sells medical devices and IT solutions used in radiology and operates research laboratory for diagnostic imaging systems and a service centre for medical equipment. Its operating segments include the sale of medical equipment used in radiology and nuclear medicine and IT solutions, Maintenance services for medical equipment as well as acceptance and specialist tests and Radiopharmaceutical production.
85GF Score

Get the complete analysis for WAR:SNT

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł381.80
Price
zł227.58
GF Value